{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:04:25Z","timestamp":1793149465202,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114219","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T20:12:41Z","timestamp":1740773561000},"page":"114219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Parthenolide ameliorates diabetic retinopathy by suppressing microglia-induced M\u00fcller cell gliosis and inflammation via the NF-\u03baB signalling"],"prefix":"10.1016","volume":"151","author":[{"given":"Zhiliang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114219_b0005","article-title":"Diabetic retinopathy: looking forward to 2030","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.intimp.2025.114219_b0010","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.intimp.2025.114219_b0015","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The Lancet Global Health Commission on Global Eye Health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.intimp.2025.114219_b0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/OPTH.S236637","article-title":"The evolving treatment of diabetic retinopathy","author":"Mansour","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.intimp.2025.114219_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583687","article-title":"The role of inflammation in diabetic retinopathy","volume":"11","author":"Forrester","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114219_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114219_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114942","article-title":"The P2X7 receptor as a new pharmacological target for retinal diseases","volume":"198","author":"Platania","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114219_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107797","article-title":"Nanoceria neuroprotective effects in the light-damaged retina: a focus on retinal function and microglia activation","volume":"188","author":"Tisi","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114219_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0305-9","article-title":"Glucose transporter 1 critically controls microglial activation through facilitating glycolysis","volume":"14","author":"Wang","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2025.114219_b0050","series-title":"Retinal Degenerative Diseases: Mechanisms and Experimental Therapy","first-page":"333","article-title":"Microglia-M\u00fcller cell interactions in the retina","author":"Wang","year":"2014"},{"issue":"1","key":"10.1016\/j.intimp.2025.114219_b0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.preteyeres.2004.07.001","article-title":"The role of M\u00fcller cells in fibrocontractive retinal disorders","volume":"24","author":"Guidry","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.114219_b0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.oftal.2015.03.009","article-title":"Effect of M\u00fcller cells on the survival and neuritogenesis in retinal ganglion cells","volume":"90","author":"Ruzafa","year":"2015","journal-title":"Arch. Soc. Esp. Oftalmol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114219_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-173","article-title":"Adaptive M\u00fcller cell responses to microglial activation mediate neuroprotection and coordinate inflammation in the retina","volume":"8","author":"Wang","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2025.114219_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-014-0224-1","article-title":"Chemokine-mediated inflammation in the degenerating retina is coordinated by M\u00fcller cells, activated microglia, and retinal pigment epithelium","volume":"12","author":"Rutar","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"21","key":"10.1016\/j.intimp.2025.114219_b0075","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1523\/JNEUROSCI.22-21-09228.2002","article-title":"Microglia\u2013M\u00fcller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration","volume":"22","author":"Harada","year":"2002","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114219_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02366-x","article-title":"Interplay between M\u00fcller cells and microglia aggravates retinal inflammatory response in experimental glaucoma","volume":"18","author":"Hu","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.intimp.2025.114219_b0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2337\/db16-0051","article-title":"CD40 in retinal M\u00fcller cells induces P2X7-dependent cytokine expression in macrophages\/microglia in diabetic mice and development of early experimental diabetic retinopathy","volume":"66","author":"Portillo","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.intimp.2025.114219_b0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1039\/C9NP00049F","article-title":"Advances in chemistry and bioactivity of parthenolide","volume":"37","author":"Freund","year":"2020","journal-title":"Nat. Prod. Rep."},{"issue":"17\u201318","key":"10.1016\/j.intimp.2025.114219_b0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2013.05.005","article-title":"Parthenolide: from plant shoots to cancer roots","volume":"18","author":"Ghantous","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.intimp.2025.114219_b0100","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41374-022-00834-3","article-title":"Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-\u03baB\/TGF-\u03b2\/Smad signaling axis","volume":"102","author":"Zhang","year":"2022","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2025.114219_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104259","article-title":"Parthenolide, a feverfew-derived phytochemical, ameliorates obesity and obesity-induced inflammatory responses via the Nrf2\/Keap1 pathway","volume":"145","author":"Kim","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.114219_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154373","article-title":"Parthenolide modulates cerebral ischemia-induced microglial polarization and alleviates neuroinflammatory injury via the RhoA\/ROCK pathway","volume":"105","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.114219_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108852","article-title":"Microglia-derived TNF-\u03b1 mediates M\u00fcller cell activation by activating the TNFR1-NF-\u03baB pathway","volume":"214","author":"Ji","year":"2022","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.114219_b0120","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s10068-018-0399-9","article-title":"Hypoglycemic effect of standardized Chrysanthemum zawadskii ethanol extract in high-fat diet\/streptozotocin-induced diabetic mice and rats","volume":"27","author":"Kim","year":"2018","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.intimp.2025.114219_b0125","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00125-010-1900-z","article-title":"Hyperglycaemia-induced pro-inflammatory responses by retinal M\u00fcller glia are regulated by the receptor for advanced glycation end-products (RAGE)","volume":"53","author":"Zong","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114219_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.641848","article-title":"Tanshinone IIA protects against cerebral ischemia reperfusion injury by regulating microglial activation and polarization via NF-\u03baB pathway","volume":"12","author":"Song","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114219_b0135","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10753-017-0571-z","article-title":"Paeoniflorin suppressed high glucose-induced retinal microglia MMP-9 expression and inflammatory response via inhibition of TLR4\/NF-\u03baB pathway through upregulation of SOCS3 in diabetic retinopathy","volume":"40","author":"Zhu","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.114219_b0140","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1007\/s00125-018-4707-y","article-title":"M\u00fcller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4, 6-dimethylpyrimidine","volume":"61","author":"McDowell","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.intimp.2025.114219_b0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.62.2.3","article-title":"KATP opener attenuates diabetic-induced M\u00fcller gliosis and inflammation by modulating Kir6. 1 in microglia","volume":"62","author":"Li","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2025.114219_b0150","first-page":"696","article-title":"Investigation of inflammatory cytokines on Muller cell expression of gliosis associated proteins","volume":"61","author":"Eastlake","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114219_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02040-8","article-title":"TRPV4-induced M\u00fcller cell gliosis and TNF-\u03b1 elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2\/STAT3\/NF-\u03baB pathway","volume":"18","author":"Li","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2025.114219_b0160","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/glia.24307","article-title":"EphA4\/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in M\u00fcller cells in an experimental glaucoma model","volume":"71","author":"Zhou","year":"2023","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.intimp.2025.114219_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10453","article-title":"Kir4. 1 may represent a novel therapeutic target for diabetic retinopathy","volume":"22","author":"Li","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"14","key":"10.1016\/j.intimp.2025.114219_b0170","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1039\/c1lc20212j","article-title":"Distinguishing drug-induced minor morphological changes from major cellular damage via label-free impedimetric toxicity screening","volume":"11","author":"Meissner","year":"2011","journal-title":"Lab Chip"},{"key":"10.1016\/j.intimp.2025.114219_b0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10753-011-9346-0","article-title":"Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities","volume":"35","author":"Mathema","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.114219_b0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12017-016-8434-6","article-title":"Parthenolide, an NF-\u03baB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model","volume":"19","author":"Khare","year":"2017","journal-title":"NeuroMol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:42:22Z","timestamp":1741254142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925002097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"alternative-id":["S1567576925002097"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114219","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parthenolide ameliorates diabetic retinopathy by suppressing microglia-induced M\u00fcller cell gliosis and inflammation via the NF-\u03baB signalling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114219"}}